Barotrauma in COVID 19 : Incidence, pathophysiology, and effect on prognosis
Copyright © 2022 Elsevier Inc. All rights reserved..
OBJECTIVES: To investigate the incidence, risk factors, and outcomes of barotrauma (pneumomediastinum and subcutaneous emphysema) in mechanically ventilated COVID-19 patients. To describe the chest radiography patterns of barotrauma and understand the development in relation to mechanical ventilation and patient mortality.
METHODS: We performed a retrospective study of 363 patients with COVID-19 from March 1 to April 8, 2020. Primary outcomes were pneumomediastinum or subcutaneous emphysema with or without pneumothorax, pneumoperitoneum, or pneumoretroperitoneum. The secondary outcomes were length of intubation and death. In patients with pneumomediastinum and/or subcutaneous emphysema, we conducted an imaging review to determine the timeline of barotrauma development.
RESULTS: Forty three out of 363 (12%) patients developed barotrauma radiographically. The median time to development of either pneumomediastinum or subcutaneous emphysema was 2 days (IQR 1.0-4.5) after intubation and the median time to pneumothorax was 7 days (IQR 2.0-10.0). The overall incidence of pneumothorax was 28/363 (8%) with an incidence of 17/43 (40%) in the barotrauma cohort and 11/320 (3%) in those without barotrauma (p ≤ 0.001). In total, 257/363 (71%) patients died with an increase in mortality in those with barotrauma 33/43 (77%) vs. 224/320 (70%). When adjusting for covariates, barotrauma was associated with increased odds of death (OR 2.99, 95% CI 1.25-7.17).
CONCLUSION: Barotrauma is a frequent complication of mechanically ventilated COVID-19 patients. In comparison to intubated COVID-19 patients without barotrauma, there is a higher rate of pneumothorax and an increased risk of death.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
|---|---|
| Enthalten in: |
Clinical imaging - 90(2022) vom: 15. Okt., Seite 71-77 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Steinberger, Sharon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Barotrauma |
|---|
| Anmerkungen: |
Date Completed 07.09.2022 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.clinimag.2022.06.014 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34445858X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34445858X | ||
| 003 | DE-627 | ||
| 005 | 20231226022824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinimag.2022.06.014 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1148.xml |
| 035 | |a (DE-627)NLM34445858X | ||
| 035 | |a (NLM)35926316 | ||
| 035 | |a (PII)S0899-7071(22)00170-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Steinberger, Sharon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Barotrauma in COVID 19 |b Incidence, pathophysiology, and effect on prognosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.09.2022 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a OBJECTIVES: To investigate the incidence, risk factors, and outcomes of barotrauma (pneumomediastinum and subcutaneous emphysema) in mechanically ventilated COVID-19 patients. To describe the chest radiography patterns of barotrauma and understand the development in relation to mechanical ventilation and patient mortality | ||
| 520 | |a METHODS: We performed a retrospective study of 363 patients with COVID-19 from March 1 to April 8, 2020. Primary outcomes were pneumomediastinum or subcutaneous emphysema with or without pneumothorax, pneumoperitoneum, or pneumoretroperitoneum. The secondary outcomes were length of intubation and death. In patients with pneumomediastinum and/or subcutaneous emphysema, we conducted an imaging review to determine the timeline of barotrauma development | ||
| 520 | |a RESULTS: Forty three out of 363 (12%) patients developed barotrauma radiographically. The median time to development of either pneumomediastinum or subcutaneous emphysema was 2 days (IQR 1.0-4.5) after intubation and the median time to pneumothorax was 7 days (IQR 2.0-10.0). The overall incidence of pneumothorax was 28/363 (8%) with an incidence of 17/43 (40%) in the barotrauma cohort and 11/320 (3%) in those without barotrauma (p ≤ 0.001). In total, 257/363 (71%) patients died with an increase in mortality in those with barotrauma 33/43 (77%) vs. 224/320 (70%). When adjusting for covariates, barotrauma was associated with increased odds of death (OR 2.99, 95% CI 1.25-7.17) | ||
| 520 | |a CONCLUSION: Barotrauma is a frequent complication of mechanically ventilated COVID-19 patients. In comparison to intubated COVID-19 patients without barotrauma, there is a higher rate of pneumothorax and an increased risk of death | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Barotrauma | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Pneumomediastinum | |
| 650 | 4 | |a Pneumothorax | |
| 700 | 1 | |a Finkelstein, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Pagano, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Manna, Sayan |e verfasserin |4 aut | |
| 700 | 1 | |a Toussie, Danielle |e verfasserin |4 aut | |
| 700 | 1 | |a Chung, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Bernheim, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Concepcion, Jose |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Sean |e verfasserin |4 aut | |
| 700 | 1 | |a Eber, Corey |e verfasserin |4 aut | |
| 700 | 1 | |a Dua, Sakshi |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobi, Adam H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical imaging |d 1996 |g 90(2022) vom: 15. Okt., Seite 71-77 |w (DE-627)NLM012624381 |x 1873-4499 |7 nnns |
| 773 | 1 | 8 | |g volume:90 |g year:2022 |g day:15 |g month:10 |g pages:71-77 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.clinimag.2022.06.014 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 90 |j 2022 |b 15 |c 10 |h 71-77 | ||